TY  - JOUR
AU  - Doneva, Miglena
AU  - Milushewa, Petya
AU  - Dimitrova, Maria
AU  - Kamusheva,  Maria
AU  - Stoitchkov, Jordan
AU  - Petrova, Guenka
AU  - Naydenova, Kremena
AU  - Krusheva, Borislava
AU  - Dimitrov, Vasil
AU  - Lakić, Dragana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4202
AB  - This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.
PB  - Taylor and Francis Ltd.
T2  - Biotechnology and Biotechnological Equipment
T1  - Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study
VL  - 36
IS  - 1
SP  - 478
EP  - 485
DO  - 10.1080/13102818.2022.2098818
ER  - 

@article{
author = "Doneva, Miglena and Milushewa, Petya and Dimitrova, Maria and Kamusheva,  Maria and Stoitchkov, Jordan and Petrova, Guenka and Naydenova, Kremena and Krusheva, Borislava and Dimitrov, Vasil and Lakić, Dragana",
year = "2022",
abstract = "This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.",
publisher = "Taylor and Francis Ltd.",
journal = "Biotechnology and Biotechnological Equipment",
title = "Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study",
volume = "36",
number = "1",
pages = "478-485",
doi = "10.1080/13102818.2022.2098818"
}

Doneva, M., Milushewa, P., Dimitrova, M., Kamusheva, M., Stoitchkov, J., Petrova, G., Naydenova, K., Krusheva, B., Dimitrov, V.,& Lakić, D.. (2022). Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study. in Biotechnology and Biotechnological Equipment
Taylor and Francis Ltd.., 36(1), 478-485.
https://doi.org/10.1080/13102818.2022.2098818

Doneva M, Milushewa P, Dimitrova M, Kamusheva M, Stoitchkov J, Petrova G, Naydenova K, Krusheva B, Dimitrov V, Lakić D. Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study. in Biotechnology and Biotechnological Equipment. 2022;36(1):478-485.
doi:10.1080/13102818.2022.2098818 .

Doneva, Miglena, Milushewa, Petya, Dimitrova, Maria, Kamusheva,  Maria, Stoitchkov, Jordan, Petrova, Guenka, Naydenova, Kremena, Krusheva, Borislava, Dimitrov, Vasil, Lakić, Dragana, "Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study" in Biotechnology and Biotechnological Equipment, 36, no. 1 (2022):478-485,
https://doi.org/10.1080/13102818.2022.2098818 . .

TY  - JOUR
AU  - Petrova, Guenka
AU  - Benbassat, Boriana
AU  - Lakić, Dragana
AU  - Dimitrova, Maria
AU  - Mitov, Konstantin
AU  - Dimitrov, Josif
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2551
AB  - The aim of this study was to explore the cost-effectiveness of short protocols including different types of gonadotropins for controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). A retrospective, observational study of the real-life practice in a specialized IVF gynaecology clinic in 2009-2013 was carried out. All women on short COH protocols were recruited into three groups: COH including recombinant follicle stimulating hormone (rFSH) and urinary-FSH (urFSH) (n = 173); including urFSH alone (n = 289); and including rFSH alone (n = 212). The cost-effectiveness of the COH protocols was explored in two different case scenarios for possible outcomes. The first case scenario took into consideration a successful live birth, and the second one, the women to achieve pregnancy with live birth. Decision modelling was done using the TreeAge 2014 Software. According to the results in the first case scenario, the rFSH plus urFSH COH approach showed the highest weighted probability (p = 0.38) of live birth, but the urFSH alternative was cost-effective. The results in the second case scenario demonstrated that the urFSH protocol was again the cost-effective alternative. These results suggest that the strategy with urFSH should be preferred in both cases, but rFSH could also be considered as a cost-effective alternative for successful live birth and achieving pregnancy and delivery, since the incremental cost-effectiveness ratio in comparison with the urFSH protocol is below the gross domestic product per capita. The combined approach of rFSH and urFSH was shown not to be cost-effective in both explored scenarios.
PB  - Taylor & Francis Ltd, Abingdon
T2  - Biotechnology & Biotechnological Equipment
T1  - Cost-effectiveness of short COH protocols with GnRH antagonists using different types of gonadotropins for in vitro fertilization
VL  - 30
IS  - 3
SP  - 614
EP  - 621
DO  - 10.1080/13102818.2016.1160796
ER  - 

@article{
author = "Petrova, Guenka and Benbassat, Boriana and Lakić, Dragana and Dimitrova, Maria and Mitov, Konstantin and Dimitrov, Josif",
year = "2016",
abstract = "The aim of this study was to explore the cost-effectiveness of short protocols including different types of gonadotropins for controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). A retrospective, observational study of the real-life practice in a specialized IVF gynaecology clinic in 2009-2013 was carried out. All women on short COH protocols were recruited into three groups: COH including recombinant follicle stimulating hormone (rFSH) and urinary-FSH (urFSH) (n = 173); including urFSH alone (n = 289); and including rFSH alone (n = 212). The cost-effectiveness of the COH protocols was explored in two different case scenarios for possible outcomes. The first case scenario took into consideration a successful live birth, and the second one, the women to achieve pregnancy with live birth. Decision modelling was done using the TreeAge 2014 Software. According to the results in the first case scenario, the rFSH plus urFSH COH approach showed the highest weighted probability (p = 0.38) of live birth, but the urFSH alternative was cost-effective. The results in the second case scenario demonstrated that the urFSH protocol was again the cost-effective alternative. These results suggest that the strategy with urFSH should be preferred in both cases, but rFSH could also be considered as a cost-effective alternative for successful live birth and achieving pregnancy and delivery, since the incremental cost-effectiveness ratio in comparison with the urFSH protocol is below the gross domestic product per capita. The combined approach of rFSH and urFSH was shown not to be cost-effective in both explored scenarios.",
publisher = "Taylor & Francis Ltd, Abingdon",
journal = "Biotechnology & Biotechnological Equipment",
title = "Cost-effectiveness of short COH protocols with GnRH antagonists using different types of gonadotropins for in vitro fertilization",
volume = "30",
number = "3",
pages = "614-621",
doi = "10.1080/13102818.2016.1160796"
}

Petrova, G., Benbassat, B., Lakić, D., Dimitrova, M., Mitov, K.,& Dimitrov, J.. (2016). Cost-effectiveness of short COH protocols with GnRH antagonists using different types of gonadotropins for in vitro fertilization. in Biotechnology & Biotechnological Equipment
Taylor & Francis Ltd, Abingdon., 30(3), 614-621.
https://doi.org/10.1080/13102818.2016.1160796

Petrova G, Benbassat B, Lakić D, Dimitrova M, Mitov K, Dimitrov J. Cost-effectiveness of short COH protocols with GnRH antagonists using different types of gonadotropins for in vitro fertilization. in Biotechnology & Biotechnological Equipment. 2016;30(3):614-621.
doi:10.1080/13102818.2016.1160796 .

Petrova, Guenka, Benbassat, Boriana, Lakić, Dragana, Dimitrova, Maria, Mitov, Konstantin, Dimitrov, Josif, "Cost-effectiveness of short COH protocols with GnRH antagonists using different types of gonadotropins for in vitro fertilization" in Biotechnology & Biotechnological Equipment, 30, no. 3 (2016):614-621,
https://doi.org/10.1080/13102818.2016.1160796 . .